SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025078
Filing Date
2021-05-06
Accepted
2021-05-06 16:45:37
Documents
44
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20210331.htm   iXBRL 10-Q 717729
2 EX-31.1 mack-ex311_9.htm EX-31.1 9566
3 EX-31.2 mack-ex312_8.htm EX-31.2 9567
4 EX-32.1 mack-ex321_6.htm EX-32.1 5717
5 EX-32.2 mack-ex322_7.htm EX-32.2 5717
  Complete submission text file 0001564590-21-025078.txt   2622899

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mack-20210331.xsd EX-101.SCH 25988
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20210331_cal.xml EX-101.CAL 19576
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20210331_def.xml EX-101.DEF 60212
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20210331_lab.xml EX-101.LAB 186695
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20210331_pre.xml EX-101.PRE 132028
11 EXTRACTED XBRL INSTANCE DOCUMENT mack-10q_20210331_htm.xml XML 327537
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 21898603
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences